We’re an NHMRC-funded national research collaboration delivering real-world evidence on the quality use of medicines in Australia.
Joined May 2021
- Tweets 409
- Following 177
- Followers 180
- Likes 596
62 Photos and videos
5 Dec 2024
Sorry to say that we have made the decision to say goodbye to Twitter/X. Thank you to all our followers. This was a difficult decision, and we hope that you will follow us on LinkedIn linkedin.com/company/mi-cre/ or learn more about our work from our website unsw.edu.au/mi-cre 👋
1
2
67
6 Nov 2024
Important study by MI-CRE investigators examining patterns of medicine use in the year prior to death by suicide. sciencedirect.com/science/ar… @anschaf @chitty_kate
1
3
53
24 Oct 2024
Congratulations @pharmer_jack on your 2024 Titan Award! What a week for MI-CRE ECRs!
Congratulations to our 2024 Titan Award winners! #OHDSI2024
Data Standards: Vocab Team
Methods Research: @Z_Linying
Open-Source Dev: Martin Lavallee
Clinical: Cindy Cai, Jung Ho Kim, Jack Janetzki
(not all honorees pictured) (1/2)
1
1
113
24 Oct 2024
Congratulations @AmyTPage, another MI-CRE EMCR achieving great things!
Congratulations to Dr Amy Page for her work on optimisation of medicines, now shortlisted as a finalist for the Health Services Research Award.
Research Australia #resausawards #healthresearch @AmyTPage
2
5
337
Medicines Intelligence CRE retweeted
22 Oct 2024
Did you miss our webinar with Dr Danielle Tran about the safety of quit #smoking medications, such as nicotine replacement therapy, varenicline and bupropion, during #pregnancy?
Watch the recording here: youtu.be/RmIl3XQfTrI?si=T96q…
2
4
271
24 Oct 2024
Congratulations @HJHansford ! A very talented ECR and we are lucky to have you involved in MI-CRE as well!
23 Oct 2024
Congratulations to @hjhansford, who was shortlisted for the @anzmusc EMCR paper of the year for his work “The smallest worthwhile effect on pain intensity of NSAIDs and exercise for back pain”
doi.org/10.1016/j.jphys.2023…
1
3
132
The @JACCJournals collaboration w/ OHDSI opens incredible potential for the community to both publish global #RWE and educate on best practices in observational research. Thank you to @hmkyale, @SengChanYou1, Yuan Lu, @nicolepratt_ & @suchard_group on a great #OHDSI2024 panel!
11
24
2,045
17 Oct 2024
We always encourage our ECRs to increase their impact through sharing their research in multiple mediums. A big shout-out to MI-CRE ECR Dr Craig Cumming for his @healthmeanswhat podcast and this week's interview with @Ria_Hopkins from @NDARCNEWS & MI-CRE on.soundcloud.com/y282U8fv54…
1
3
72
Medicines Intelligence CRE retweeted
11 Oct 2024
Just published! This review highlights the limited data on the safety of alcohol pharmacotherapies in pregnancy. Balancing untreated AUDs against the medication-related risks is key to supporting the pregnant individual & developing child. @UWAresearch
doi.org/10.1007/s40263-024-0…
6
13
748
15 Oct 2024
Fantastic to see the global reach of MI-CRE, with several of our E/MCRs teaching at ACPE in Tokyo this year. Well done to @michaelfalster, @Juliana_OCosta and Ben Daniels for leading sessions this year and representing @MedIntelCRE .
12 Oct 2024
Great start to #ACPE2024 Tokyo with the education session on Database Pharmacoepidemiology. Thanks to all my fellow presenters! @MedIntelCRE @Juliana_OCosta
4
167
12 Sep 2024
These are called ‘add-on’ therapies and are usually taken with metformin, the first-line treatment for T2DM. There are 2 types: SGLT2 inhibitors and GLP-1 RA. Starting these add-on therapies early is crucial to maximise heart and kidney benefits for people with type 2 DM. 2/4
1
1
68
12 Sep 2024
MI-CRE researchers studied Australians aged 40 who began metformin in 2018 - 2020. They found 2/3 of patients did not receive any add-on therapy within 2 yrs of starting metformin. 3/4
1
1
49
12 Sep 2024
We must prioritise early access to these medicines for Australians with type 2 diabetes to protect their hearts and kidneys and save lives. bpspubs.onlinelibrary.wiley.… 4/4
1
116
12 Sep 2024
Over 1M Australians are living with T2DM, but it is heart and kidney disease that are the major causes of death and sickness. There are diabetes medicines available that can also protect their hearts and kidneys, and potentially save lives, but many are missing out. 🧵1/4
1
2
2
149
Medicines Intelligence CRE retweeted
9 Sep 2024
Medications to treat alcohol use disorders are severely underutilised in Australia.
Thrilled to share my first published #PhD paper! @UWAresearch
academic.oup.com/alcalc/arti…
10
13
629
12 Sep 2024
Congratulations @EbonyQuintrell on your first PhD paper being published. Ebony also won the People's Choice award at our recent MI-CRE Symposium for her presentation on this work. A rising star in MI-CRE!
11 Sep 2024
Chuffed to see @EbonyQuintrell first PhD paper available online.
The paper highlights huge time lags between the onset of #alcohol dependence and treatment, as well as a huge underutilisation of medications.
Congrats EQ!
doi.org/10.1093/alcalc/agae0…
1
4
125
12 Sep 2024
Latest study by MI-CRE researchers shows Australians with type 2 diabetes missing out on crucial medications to protect from heart and kidney disease unsw.edu.au/newsroom/news/20…
1
1
2
339
1 Sep 2024
Fresh on the heals of our highly successful #MICRE2024 Symposium, several of our ECRs flew off to Berlin for the 40th ISPE Conference in Berlin to present their work. Well done team!
1
2
5
241
3 Sep 2024
And congratulations to another one of our ECRs @DrMasakoAraki whose poster was selected as a Spotlight Poster for the Drug Utilisation Study section of the conference.
1
1
97
1 Sep 2024
Our Director @SalPearson was thrilled to be a part of this great new conference and discussed the value of using real-world evidence in health technology assessment.
30 Aug 2024
An all-star speaker line-up featuring international & local real-world evidence experts at the limbic's #ResearchREWRITTEN conference at @PeterMacCC
Convened by: @DrBenTran
@rdienstmann @torgrimtandstad @Fannychini @winsoncheung @AzadOncology @SalPearson @weeloonong
2
3
286